Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Rosuvastatin
Drug ID BADD_D01971
Description Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]
Indications and Usage Used as an adjunct to dietary therapy to treat primary hyperlipidemia (heterozygous familial and nonfamilial), mixed dyslipidemia and hypertriglyceridemia. Also indicated for homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering therapies or when other such therapies are not available. Furthermore, it is used to slow the progression of atherosclerosis and for primary prevention of cardiovascular disease.
Marketing Status Prescription
ATC Code C10AA07
DrugBank ID DB01098
KEGG ID D08492
MeSH ID D000068718
PubChem ID 446157
TTD Drug ID D0JE2E
NDC Product Code 47335-986; 31722-883; 49252-064; 47335-985; 50268-710; 16729-285; 70518-1601; 50268-709; 71335-1446; 47335-984; 69238-1148; 68382-629; 71335-0749; 61919-786; 16729-286; 50090-3177; 16729-284; 50268-711; 70771-1484; 31722-882; 50090-2724; 31722-884; 68071-2326; 31722-885; 70518-1219; 70771-1482; 70771-1481; 49252-062; 70518-0986; 70771-1483; 71335-0606; 50228-117; 47335-987; 68382-628; 68382-627; 16729-287; 68788-7971; 50228-118; 50228-119; 49252-061; 68788-7673; 50228-116; 50090-4909; 72189-065; 49252-063; 50090-2725; 69238-1147; 70269-400; 69238-1146; 71205-044; 68382-630; 70518-1384; 69238-1149
Synonyms Rosuvastatin Calcium | Calcium, Rosuvastatin | Crestor | Rosuvastatin | ZD4522 | ZD 4522
Chemical Information
Molecular Formula C22H28FN3O6S
CAS Registry Number 287714-41-4
SMILES CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Aphonia19.19.01.002; 22.02.05.024; 17.02.08.0090.000088%
Arrhythmia02.03.02.0010.000751%Not Available
Arteriosclerosis24.04.02.0010.000046%Not Available
Arteriosclerosis coronary artery24.04.04.012; 02.02.01.0110.000023%Not Available
Arthralgia15.01.02.0010.002738%
Arthritis15.01.01.0010.000530%
Arthropathy15.01.01.003--Not Available
Ascites02.05.04.002; 09.01.05.003; 07.07.01.001--
Aspartate aminotransferase increased13.03.01.0060.001104%
Asphyxia22.02.02.001; 12.01.08.0110.000035%Not Available
Asthenia08.01.01.0010.002870%Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Ataxia08.01.02.004; 17.02.02.001--
Atrial fibrillation02.03.03.0020.000662%
Atrioventricular block02.03.01.0020.000221%Not Available
Autoimmune hepatitis10.04.09.001; 09.01.07.0190.000309%Not Available
Axonal neuropathy17.09.03.0150.000177%Not Available
Back pain15.03.04.0050.000971%
Bladder cancer20.03.04.001; 16.08.01.001--Not Available
Blepharospasm17.17.02.001; 06.05.01.0010.000088%Not Available
Blister12.01.06.002; 23.03.01.001--Not Available
Blood albumin decreased13.09.01.0010.000088%Not Available
Blood bilirubin increased13.03.01.008--
Blood bilirubin unconjugated increased13.03.01.0240.000132%Not Available
Blood calcium increased13.11.01.0030.000177%Not Available
Blood cholesterol abnormal13.12.01.0090.000177%Not Available
Blood cholesterol decreased13.12.01.0010.000177%Not Available
Blood cholesterol increased13.12.01.0020.001192%
Blood creatine phosphokinase13.04.01.0090.000088%Not Available
Blood creatine phosphokinase increased13.04.01.0010.003842%
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 22 Pages